Dr Agarwals Health Care Ltd (AGARWALEYE)
₹517.75
Mkt cap
₹16,298 Cr
P/E ratio
110.00
P/B
8.10
Div yield
0.00%
ROE
6.81%
ROCE
11.10%
EPS (TTM)
₹4.71
Book value
₹64
52W range
407–561
Sector
Healthcare
Price history
Previous close
Incorporated in 2010, [1] Dr. Agarwal’s Health Care offers a wide array of eye care services, which include cataract and refractive surgeries, consultations, diagnoses, and non-surgical treatments. Additionally, they provide optical products, contact lenses, accessories, and pharmaceutical items related to eye care. [2]
NSE AGARWALEYEBSE 544350
Health check
Mixed
ValuationExpensive
ProfitabilityWeak
GrowthHigh
TechnicalsBullish
52-week range
−7.66% from high₹518
₹407+27.35% from low₹561
Current
₹517.75
Prev close
₹514.65
Day
+0.60%
Price performance
1D
+0.60%
1W
+0.89%
1M
−5.22%
3M
+15.44%
6M
+19.08%
1Y
+19.50%
YTD
+3.15%
Financials
Revenue, profit & margin
P/E ratio
110.0×
AGARWALEYE is 124% above the sector median of 49.1×
AGARWALEYE110.0×
Sector median49.1×
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 333 | 349 | 403 | 417 | 431 | 460 | 487 | 499 | 530 | 564 | 614 | |
| Expenses | 244 | 241 | 300 | 310 | 316 | 329 | 360 | 363 | 386 | 403 | 444 | |
| Operating Profit | 89 | 108 | 104 | 107 | 115 | 131 | 128 | 136 | 144 | 161 | 170 | |
| OPM % | 27% | 31% | 26% | 26% | 27% | 28% | 26% | 27% | 27% | 29% | 28% | |
| Other Income | 12 | 20 | 6 | 12 | 13 | 13 | 13 | 8 | 11 | 14 | 6 | |
| Interest | 22 | 27 | 27 | 28 | 28 | 25 | 25 | 23 | 21 | 22 | 23 | |
| Depreciation | 43 | 47 | 56 | 57 | 58 | 60 | 63 | 68 | 69 | 77 | 78 | |
| Profit before tax | 36 | 54 | 27 | 33 | 41 | 59 | 54 | 54 | 65 | 77 | 75 | |
| Tax % | 37% | 24% | 33% | 36% | 31% | 27% | 29% | 32% | 33% | 35% | 27% | |
| Net Profit | 23 | 41 | 18 | 21 | 28 | 43 | 38 | 36 | 44 | 50 | 55 | |
| EPS in Rs | 0.72 | 1.03 | 0.95 | 0.94 | 1.07 | 1.25 | 1.43 | |||||
| Raw PDF |
Earnings
Results dates & reactionsNo upcoming results date on calendar.
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
Avg earnings-day move −0.10% · closed higher next day 3 of last 7
| Q3FY25 | Q4FY25 | Q1FY26 | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 | |
|---|---|---|---|---|---|---|---|
| Broadcast | 15 Feb '25◦ | 29 May '25 | 12 Aug '25◦ | 30 Oct '25◦ | 3 Feb '26◦ | 21 May '26◦ | 4 Aug '26◦ |
| Earnings day | −3.26% | −1.64% | +0.41% | −2.44% | +1.04% | −0.36% | +5.58% |
| +1 day | −5.06% | −4.07% | +4.29% | −0.06% | +2.41% | −0.29% | +7.86% |
| +5 days | −8.31% | +0.47% | +1.26% | −3.04% | +2.71% | +0.05% | +3.64% |
| +15 days | −4.31% | +15.60% | −5.36% | −2.37% | +1.23% | −8.69% | +1.02% |
| +30 days | −0.69% | +23.81% | +8.72% | −4.03% | −4.98% | −1.78% | — |
| Filing | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL |
Corporate actions
Last 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Shareholding
as of Jun 202632.34%Promoter
Promoters32.34%
FIIs57.97%0.03
DIIs7.72%0.11
Public1.97%0.10
Ownership trend
Peers
8 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| APOLLOHOSP | ₹8,650.00 | 59.12 | 1,24,374 | 0.23% | 610 | +34.17% | 7,044 | +20.56% | 17.45% |
| MAXHEALTH | ₹984.80 | 64.02 | 95,852 | 0.20% | 323 | +4.87% | 2,366 | +16.70% | 14.71% |
| MANIPALHOS | ₹725.20 | 107.73 | 95,391 | 0.00% | 243 | −7.86% | 3,091 | +38.12% | 12.10% |
| ASTERDM | ₹785.75 | 189.76 | 68,492 | 0.38% | 29 | −46.12% | 1,311 | +21.60% | 11.40% |
| FORTIS | ₹905.00 | 64.04 | 68,324 | 0.11% | 273 | +3.39% | 2,545 | +17.46% | 13.45% |
| MEDANTA | ₹1,469.80 | 69.02 | 39,519 | 0.03% | 157 | −0.18% | 1,304 | +26.50% | 17.37% |
| NH | ₹1,858.50 | 44.06 | 37,980 | 0.24% | 207 | +5.71% | 2,684 | +78.05% | 15.50% |
| AGARWALEYE | ₹514.10 | 110.36 | 16,298 | 0.00% | 55 | +50.52% | 614 | +25.97% | 11.12% |
| Median: 29 Co. | ₹514.10 | 49.13 | 6,632 | 0.03% | 31 | +18.98% | 406 | +22.28% | 14.71% |
Filings
Annual reports2
Concall transcripts21
Credit ratings6
Announcements5
Announcement under Regulation 30 (LODR)-Newspaper Publication 29 Aug - Newspaper Advertisement - Sixteenth Annual General Meeting of Dr. Agarwals Health Care Limited, Instructions for e-Voting and Other Related Information, is submitted.Reg. 34 (1) Annual Report. 28 AugSixteenth Annual General Meeting Of Dr Agarwals Health Care Limited To Be Held On September 21, 2026 28 AugAnnouncement under Regulation 30 (LODR)-Press Release / Media Release 27 Aug - World’s first Pinhole Pupilloplasty Centre launched in Chennai on August 27, 2026.Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 25 Aug - Company officials to attend Jefferies India Forum on September 16, 2026 and Kotak Healthcare Forum on September 17-18, 2026.